Evidence map›Paper›PMID 38234056›Full record

Observational studyHealth services research2024

Maternal chronic hypertension in women veterans.

Ceshae C Harding, Karen M Goldstein, Sarah A Goldstein, Sarahn M Wheeler, Nia S Mitchell, Laurel A Copeland

Open access · hybridAbstract readObservational Study
In one paragraph

Observational study in Health services research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
2.3field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Review
  3. Maternal chronic hypertension in women veterans.Health services research · 2024
    Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Ceshae C HardingDepartment of Medicine, Division of General Internal Medicine, Duke University, Durham, North Carolina, USA.ORCID 0000-0001-9930-0852
Karen M GoldsteinDepartment of Medicine, Division of General Internal Medicine, Duke University, Durham, North Carolina, USA.ORCID 0000-0003-4419-5869
Sarah A GoldsteinDepartment of Medicine, Division of Cardiovascular Medicine, Yale New Haven Health System, New Haven, Connecticut, USA.
Sarahn M WheelerDepartment of Obstetrics and Gynecology, Division of Maternal-Fetal Medicine, Duke University, Durham, North Carolina, USA.
Nia S MitchellDepartment of Medicine, Division of General Internal Medicine, Duke University, Durham, North Carolina, USA.
Laurel A CopelandVA Central Western Massachusetts Healthcare System, Leeds, Massachusetts, USA.
Duke University · USVA Central Western Massachusetts Healthcare System · USYale New Haven Health System · US

Funding

NRSA Training CoreTL1TR002555 · NCATS · DUKE UNIVERSITY · PI EDELMAN, DAVID · 2018 to 2022
$3.7M
NCATS NIH HHS TL1 TR002555NCATS NIH HHS TL1TR002555
6 · The paper itself

Abstract

objectiveTo describe the prevalence of maternal chronic hypertension (MCH), assess how frequently blood pressure is controlled before pregnancy among those with MCH, and explore management practices for antihypertensive medications (AHM) during the pre-pregnancy and pregnancy periods. DATA SOURCES, STUDY SETTING, AND STUDY

designWe conducted a descriptive observational study using data abstracted from the Veterans Health Administration (VA) inclusive of approximately 11 million Veterans utilizing the VA in fiscal years 2010-2019. DATA COLLECTION/EXTRACTION

methodsVeterans aged 18-50 were included if they had a diagnosis of chronic hypertension before a documented pregnancy in the VA EMR. We identified chronic hypertension and pregnancy with diagnosis codes and defined uncontrolled blood pressure as ≥140/90 mm Hg on at least one measurement in the year before pregnancy. Sensitivity models were conducted for individuals with at least two blood pressure measurements in the year prior to pregnancy. Multivariable logistic regression explored the association of covariates with recommended and non-recommended AHMs received 0-6 months before pregnancy and during pregnancy. PRINCIPAL

findingsIn total, 8% (3767/46,178) of Veterans with a documented pregnancy in VA data had MCH. Among 2750 with MCH meeting inclusion criteria, 60% (n = 1626) had uncontrolled blood pressure on at least one BP reading and 31% (n = 846) had uncontrolled blood pressure on at least two BP readings in the year before pregnancy. For medications, 16% (n = 437) received a non-recommended AHM during pregnancy. Chronic kidney disease (OR = 3.2; 1.6-6.4) and diabetes (OR = 2.3; 1.7-3.0) were most strongly associated with use of a non-recommended AHM during pregnancy.

conclusionsInterventions are needed to decrease the prevalence of MCH, improve preconception blood pressure control, and ensure optimal pharmacologic antihypertensive management among Veterans of childbearing potential.

Indexed as

Diabetes MellitusHypertensionVeteransAntihypertensive AgentsBlood PressureFemaleHumansPregnancyAntihypertensive Agentschronic hypertensioncomorbiditymaternalmaternity care coordinationpregnancyveteranswomen

Identifiers

PMID38234056
PMCPMC10915474
OpenAlexW4390983581

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.